Withdrawn
This medicine is now withdrawn from use in the European Union.
Overview
The marketing authorisation for Valdyn has been withdrawn at the request of the marketing authorisation holder.
This EPAR was last updated on 23/08/2004
Authorisation details
| Product details | |
|---|---|
| Name |
Valdyn
|
| Agency product number |
EMEA/H/C/000432
|
| Active substance |
valdecoxib
|
| International non-proprietary name (INN) or common name |
valdecoxib
|
| Therapeutic area (MeSH) |
|
| Anatomical therapeutic chemical (ATC) code |
M01AH03
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Pharmacia Europe EEIG
|
| Revision |
0
|
| Date of issue of marketing authorisation valid throughout the European Union |
27/03/2003
|
| Contact address |
Hillbottom Road
High Wycombe Buckinghamshire HP12 4PX United Kingdom |
Product information
02/03/2004 Valdyn - EMEA/H/C/000432 -
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Pharmacotherapeutic group
Antiinflammatory and antirheumatic products
Therapeutic indication
Therapeutic indication
Symptomatic relief in the treatment of osteoarthritis or rheumatoid arthritis.
Treatment of primary dysmenorrhoea.